Weil, Jones Day on Shanghai Pharma’s $557 mln acquisition of U.S. Cardinal Health’s China business
BY John Kang, Reuters |
Weil, Gotshal & Manges has advised Shanghai Pharmaceuticals on its $557 million acquisition of U.S. drug distributor Cardinal Health’s China business, which turned to Jones Day for advice. Chinese firm Zhong Lun Law Firm served as PRC counsel to Shanghai Pharma.